Translating molecular pathology into cancer diagnostics

精确肿瘤学，即选择与治疗相匹配的特定分子特征(生物标记物)来治疗癌症患者，已经改变了癌症患者的治疗方式。然而，许多用于临床护理的生物标志物并不可靠，没有发挥其作用。我将利用创新的高通量实验室技术，将基础发现、临床试验和新诊断开发的新研究测试转化为提高患者结果的新研究测试。

Precision oncology, the treatment of cancer patients selected with a particular molecular characteristic (biomarker) matched to a therapy, has transformed the treatment of cancer patients. However, many biomarkers used for clinical care are not reliable and do not perform their role. I will translate new research tests from fundamental discovery, clinical trials and the development of novel diagnostics using innovative high throughput laboratory technologies to enhance patient outcomes.